WHO ICTRP trial
Effect of external trigeminal nerve stimulation for drug-resistant epilepsy
ChiCTR2200062522 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200062522 |
|---|---|
| Public title | Effect of external trigeminal nerve stimulation for drug-resistant epilepsy |
| Scientific title | Effect of external trigeminal nerve stimulation for drug-resistant epilepsy |
| Primary sponsor | Xi'an Central Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 2 |
| Countries | China |
| Conditions | drug-resistant epilepsy |
| Interventions | Experimental group:Basic medicine + eTNS;control group:Basic drugs + Sham stimulation |
| Registration date | Aug 10, 2022 |
| Target size | Experimental group:30;control group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: